To evaluate the advantages, disadvantages, safety, and surgical applicability of the pulsed electron avalanche knife (PEAK-fc), a new electrosurgical knife for "cold" and tractionless cutting, in vitreoretinal surgery. PEAK-fc is equipped with an integrated fiberoptic that makes bimanual procedures in intraocular surgery possible.
elongated microelectrode in physiologic medium or tissue. PEAK-fc operates with voltages between 300 V and 600 V and pulses of Ϸ100 microseconds in duration, each of them consisting of a burst of several tens of "minipulses" (Fig. 1) . Pulsed plasma-mediated discharges rapidly vaporize and ionize liquid and tissue in close proximity to the probe. Duration of the pulsed waveform is chosen to minimize both cavitation-related and heat diffusion-related damage. [1] [2] [3] [4] A protruding wire of 0.3 mm or 0.6 mm in length and 50 m in diameter offers convenient cutting and coagulation under visual control.
Applicability of the intraocular laser systems based on CO 2 and Ho:YAG lasers has been limited due to strong variability in the ablation depth and low reproducibility 5 as well as to deep collateral damage produced in the surrounding tissue. 6, 7 Although Er:YAG 8 -12 and ArF excimer lasers 13, 14 are capable of precise dissection of ocular tissue, they have failed to achieve widespread acceptance in clinical practice due to their prohibitively high cost, large size, and relatively slow pace. In contrast, the electrosurgical instrument PEAK-fc allows for reproducible and reliable retinal dissection with induction of only minimal collateral damage at the edges of the cut. 15 In vitro human and in vivo animal studies have demonstrated that the penetration depth and the extent of collateral damage with PEAK-fc mainly depend on voltage, probe length, and its distance from the retina. 15 The purpose of the current study was to further evaluate the safety and effectiveness of this new cutting device in clinical settings. The efficacy of PEAK-fc in various surgical maneuvers for patients undergoing vitreoretinal surgery for proliferative diabetic retinopathy, proliferative vitreoretinopathy, and subretinal hemorrhages in age-related macular degeneration was tested.
Materials and Methods

PEAK-2nd Version (PEAK-fc; Carl Zeiss Meditec, Jena, Germany)
In contrast to the first version of PEAK, which operated with submicrosecond pulses of 3 kV to 6 kV, 1-3 advanced PEAK-fc operates at much lower voltages (300 -600 V) and much longer pulses (Ϸ100 microseconds) consisting of a burst of several tens of minipulses (Fig. 1B) . The cutting part of the PEAK-fc probe is a protruding tungsten wire with a diameter of 50 m (Fig. 1A) . The wire used in this study extends from the glass insulator 0.6 mm in length. The glass insulator itself has an outer diameter of 0.6 mm and is enclosed in a 20-gauge stainless steel return electrode. The glass insulator in PEAK-fc also serves as a light pipe providing integrated intraocular illumination (Fig. 1) . This facilitates bimanual procedures in vitreoretinal surgery with a lower risk of unintended tissue damage due to improved ergonomics. In addition, a coagulation mode has been integrated.
In the present study, PEAK-fc parameters varied as follows: pulse repetition rate, 30 -100 Hz; number of minipulses per pulse, 25-60; and pulse duration, 100 microseconds. Voltage ranged from 350 V to 600 V. The parameters selected for the particular maneuvers are listed in Table 1 .
Patients and Surgical Approach
Eighteen patients were consecutively enrolled in this study. Patients were chosen with regard to the preoperative situation potentially suitable for the surgical maneuvers that could be performed with PEAKfc. Surgery was performed after obtaining written informed consent concerning the intraoperative use of PEAK-fc, and follow-up visits occurred at 1 week and 4 weeks and at 3-month intervals thereafter. An external review board monitored the study. Exclusion criteria were history of glaucoma, visual acuity of less than 20/800 in the fellow eye, or a medical history requiring systemic anticoagulation.
One eye of each patient (Table 2 ) was included in the study. There were 10 men and 8 women (mean age, 64 years; range, 53-79 years). Preoperative diagnoses included tractional retinal detachment involving the fovea in eyes with diabetic retinopathy (6 eyes), proliferative vitreoretinopathy (5 eyes), age-related macular degeneration with subretinal hemorrhage (5 eyes), tractive epiretinal membrane (macular pucker) with a history of central retinal vein occlusion (1 eye), and posterior capsule fibrosis with prolonged proliferative diabetic retinopathy (1 eye). All patients underwent complete ophthalmologic examinations including visual acuity testing, slit-lamp examination, intraocular pressure determination, and fundus biomicroscopy using a 78-diopter lens (Volk, Mentor, OH).
Surgery consisted of standard three port pars plana vitrectomy using a commonly available vitrectomy machine (Megatron, Geuder, Germany). The study design provided the optional use of PEAK-fc within a surgical procedure for one or more maneuvers at the discretion of the surgeon. The following specific maneuvers were tested during surgery (Table 1) : drainage retinotomy for patients with subretinal hemorrhages; relaxing retinotomy for patients with prolonged retinal detachment; transection and incision of epiretinal membranes in proliferative diabetic retinopathy, proliferative vitreoretinopathy, or macular pucker; surgical posterior membranectomy with posterior capsule fibrosis in prolonged proliferative diabetic retinopathy; and retinal vessel coagulation to stop intraoperative bleeding from vascularized epiretinal membranes in proliferative diabetic retinopathy. All maneuvers were recorded on videotape, permitting documentation of the efficacy and possible complications.
Results
A total of 18 consecutive patients were treated with PEAK-fc. In each maneuver, PEAK-fc parameters were initially set at the values determined by animal and in vitro studies as safe and efficient for dissection of neurosensory retinal layers without damaging the underlying retinal pigment epithelium 15 : voltage, 350 V; pulse repetition rate, 30 Hz; pulse duration, 100 microseconds; and 30 minipulses per pulse. Parameters were increased until the desired tissue effect was observed. Typical effective settings for each maneuver performed are presented in Table 1 .
Transection and incision of epiretinal membranes, both vascular (4 cases) and avascular (6 cases), were rapidly and consistently accomplished without complications in 10 patients ( Fig. 2 ; Table 2 ). One to three membranes were peeled in each of the 10 patients who had traction retinal detachment with proliferative diabetic retinopathy, proliferative vitreoretinopathy, or macular pucker (Table 2) . A bimanual approach (fixating the proliferative vitreoretinopathy membrane with an intraocular forceps or vitrector and simultaneously illuminating the vitreous and cutting with PEAK-fc) obviously facilitated precise cutting with minimal or no traction and avoided potential complications of inadvertent retinal tears, bleeding, or collateral injury (Fig. 2) . Except for strong adherent membranes and intraretinal proliferative vitreoretinopathy, membranes could be removed in all cases.
Removal of vascular membranes required higher energy levels (up to 450 V) for successful vessel dissection. Intraoperative hemorrhages from perfused nonfibrotic vessels occurred in two maneuvers and were easily stopped using the coagulation mode of PEAK-fc (level 5).
Drainage and relaxing retinotomies on attached and detached retina were easily performed without complications (Figs. 3 and 4) . PEAK-fc cuts showed sharp edges with hardly visible whitening, indicating little collateral damage. Minor self-limited bleeding was observed at the margin of one retinotomy. Drainage retinotomy was performed on five patients who had submacular bleeding associated with age-related macular degeneration (Table 2) . Although extensive bleeding in 3 of these patients required 180°retino-tomy after induction of an iatrogenic retinal detachment (Fig. 3) , the other 2 retinotomies were performed extrafoveolarly on attached retina (Fig. 4) . In the latter cases, PEAK-fc parameters previously determined as safe for dissection of the neurosensory retina 15 were used, and no damage of the retinal pigment epithelium or choroid occurred. Subretinal bleeding and choroidal neovascularizations could be successfully removed. For retinotomies on attached retina, the PEAK-fc probe was slowly moved along the surface of the retina with a velocity of Ϸ1 mm/s. Retinotomies on detached retina allowed cutting laterally by deeper tracking of the PEAK-fc probe, while velocity reached up to Ϸ2 mm/s.
Relaxing retinotomy was performed on three patients who had prolonged retinal detachment with tense and contracted retina ( Table 2 ). In comparison to dissection of attached retina, we used slightly increased PEAK-fc parameters (Table 1) . Before dissection, retinal vessels were coagulated using the PEAK-fc coagulation mode (level 5) to avoid intraoperative bleeding (Fig. 5) . These coagulated vessels required increased PEAK-fc parameters for successful dissection (Table 1) .
For one patient who had massive capsule fibrosis after vitrectomy and silicone oil tamponade for treatment of proliferative retinopathy, we decided to perform posterior membranectomy using PEAK-fc for transection of the thickened and partially vascularized membrane (Table 2) . Although maximal power of PEAK-fc was used (voltage, 600 V; pulse repetition rate, 100 Hz; pulse duration, 100 microseconds; and 60 minipulses per pulse), ablation of the posterior capsule membrane was difficult. However, it finally could be removed, allowing inspection of the posterior segment.
Complications included minor bleeding during one retinotomy, which stopped spontaneously, and bleeding from vascularized epiretinal membranes in proliferative diabetic retinopathy. Intraoperative bleeding from these vessels was successfully stopped using the coagulation mode (level 5) of PEAK-fc. Formation of gas bubbles similar to those seen during conventional diathermy has been observed. However, for the PEAK-fc parameters used, the amount of bubbles could be reduced to a minimum, and controlled cuts could be performed despite the generation of gas bubbles in all surgical procedures.
Discussion
Along with improved understanding of vitreoretinal diseases, ongoing development of microsurgical techniques in vitreoretinal surgery has occurred. Special miniaturized instruments have been developed to perform tissue transection, removal, and coagulation within the vitreous cavity. Although blades, scissors, forceps, cautery systems, and other devices have been continually refined, difficulties and limitations are still encountered, particularly as increasingly finer surgical maneuvers are attempted. We report our initial clinical experience with the new cold cutting device PEAK-fc for maneuvers in vitreoretinal surgery. Removal of contractile fibrocellular and fibrovascular epiretinal membranes (e.g., in proliferative vitreoretinopathy and proliferative diabetic retinopathy) requires surgical cutting in the most precise way and with the least amount of traction. When removing epiretinal membranes, especially the less experienced surgeon might cause iatrogenic breaks or retinal injury using standard forceps or scissors. 16 The delicacy of the retina, the sharpness of the instruments, and the challenges of visualizing the posterior pole of the eye all contribute to potentially harmful unintended results. Although current procedures for the removal of proliferative vitreoretinopathy membranes usually exert a certain degree of traction on the tissue that can potentially damage retinal structures and cause iatrogenic tears or hemorrhages, PEAK-fc dissects tissue with minimal traction, thus preventing unintended tears and hemorrhages. In addition, the integrated light source of PEAK-fc facilitates intraocular procedures and makes vitreoretinal surgery safer. The PEAK-fc probe allows a bimanual approach for the surgeon by using the free hand to prepare the region of interest with maximum safety, simultaneously facilitating illumination and dissection of ocular tissue with the other hand.
In a safe and quick way, we demonstrated that PEAK-fc allows the surgeon to perform large retinotomies that are required for the removal of extensive subretinal hemorrhages or for macular translocation. Retinal cuts with PEAK-fc showed almost no thermal damage in the cutting zone, thus confirming observations made in preclinical postmortem and animal studies. 15 One further advantage of PEAK-fc is the possibility of power adjustment for different tissue structures, which allows cuts through soft tissue without affecting harder tissues such as vascular walls. Thus, when working adjacent to vessels, potential damage to these vessels can be minimized. 15 However, even in the case of intraoperative bleeding, it can be immediately stopped using the coagulation mode of PEAK-fc without having to remove the instrument, as required during conventional surgery. Maximal power of PEAK-fc dissection of a thick fibrotic posterior capsule membrane turned out to be relatively difficult. Increasing the absolute voltage power available might be an option to solve similar problems in future applications of PEAK-fc.
One side effect of PEAK-fc application is the formation of gas bubbles potentially impairing the surgeon's view on the retina or other operating site. The amount of gas bubbles generated by PEAK-fc can be compared with the gas development in conventional intraocular diathermy. However, in the present study, the development of gas did not reduce visibility to a degree that would have made surgery unsafe in any of the performed procedures.
In summary, PEAK-fc was successfully used for a variety of surgical maneuvers commonly encountered in patients undergoing vitreoretinal and anterior segment surgery. Advantages of this new technology include sharply defined transection and incision of epiretinal membranes, fine coagulation of vascularized epiretinal tissue during surgery for diabetic traction detachment, and traction-free dissection of attached or elevated retina. PEAK-fc appears to be a promising cutting device for intraocular surgery, potentially allowing a higher level of microsurgical precision in vitreoretinal surgery. However, due to the preliminary nature of the present investigation, additional studies incorporating larger patient series will be required to accurately determine the role of this new instrument in vitreoretinal surgery.
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